Cargando…

A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1

Patients diagnosed with exudative neovascular age-related macular degeneration are commonly treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, response to treatment is heterogeneous, without a clinical explanation. Predicting suboptimal response at baseline will enable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chorev, Michal, Haderlein, Jonas, Chandra, Shruti, Menon, Geeta, Burton, Benjamin J. L., Pearce, Ian, McKibbin, Martin, Thottarath, Sridevi, Karatsai, Eleni, Chandak, Swati, Kotagiri, Ajay, Talks, James, Grabowska, Anna, Ghanchi, Faruque, Gale, Richard, Hamilton, Robin, Antony, Bhavna, Garnavi, Rahil, Mareels, Iven, Giani, Andrea, Chong, Victor, Sivaprasad, Sobha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142969/ https://www.ncbi.nlm.nih.gov/pubmed/37109349 http://dx.doi.org/10.3390/jcm12083013

Ejemplares similares

Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes
por: Sivaprasad, Sobha, et al.
Publicado: (2023)

Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
por: Sivaprasad, Sobha, et al.
Publicado: (2021)

Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes
por: Sivaprasad, Sobha, et al.
Publicado: (2023)

Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration
por: Talks, J S, et al.
Publicado: (2017)

Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
por: McKibbin, M, et al.
Publicado: (2015)

Barriers in establishing systematic diabetic retinopathy screening through telemedicine in low- and middle-income countries
por: Yim, Daniel, et al.
Publicado: (2021)

Study protocol on prevalence of non-exudative macular neovascularisation and its contribution to prediction of exudation in fellow eyes with unilateral exudative AMD (EYE-NEON)
por: Thottarath, Sridevi, et al.
Publicado: (2023)

Correlation of Optical Coherence Tomography Angiography Characteristics with Visual Function to Define Vision-Threatening Diabetic Macular Ischemia
por: Tsai, Wei-Shan, et al.
Publicado: (2022)

Automated summarisation of SDOCT volumes using deep learning: Transfer learning vs de novo trained networks
por: Antony, Bhavna Josephine, et al.
Publicado: (2019)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
por: Hykin, Philip, et al.
Publicado: (2016)

Visual acuity outcome of stable proliferative diabetic retinopathy following initial complete panretinal photocoagulation
por: Fu, Dun Jack, et al.
Publicado: (2022)

Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy
por: Karatsai, Eleni, et al.
Publicado: (2021)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
por: Patel, Praveen J, et al.
Publicado: (2017)

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma
por: Ghanchi, Faruque, et al.
Publicado: (2022)

A feature agnostic approach for glaucoma detection in OCT volumes
por: Maetschke, Stefan, et al.
Publicado: (2019)

Adaptive systems : an introduction /
por: Mareels, Iven, 1959-
Publicado: (1996)

Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
por: Talks, S. James, et al.
Publicado: (2019)

Evaluation of real-world early response of DMO to aflibercept therapy to inform future clinical trial design of novel investigational agents
por: Halim, Sandra, et al.
Publicado: (2020)

Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema
por: Pearce, Ian, et al.
Publicado: (2019)

Adaptive systems: an introduction
por: Mareels, Iven, et al.
Publicado: (1996)

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
por: Garweg, Justus G., et al.
Publicado: (2022)

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018)

Obfuscated Memory Malware Detection in Resource-Constrained IoT Devices for Smart City Applications
por: Shafin, Sakib Shahriar, et al.
Publicado: (2023)

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
por: Eleftheriadou, Maria, et al.
Publicado: (2018)

The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice
por: Pearce, Ian, et al.
Publicado: (2022)

High performance control
por: Tay, Teng-Tiow, et al.
Publicado: (1998)

Vademecum del cuidador de Caballos/
por: McKibbin, Lloyd S.
Publicado: (1979)

A GWEP COLLABORATION: IMPLEMENTING THE AWV IN A RURAL PRIMARY CARE CLINIC
por: McKibbin, Christine
Publicado: (2019)

Decolonising Canadian water governance: lessons from Indigenous case studies
por: McKibbin, Corey
Publicado: (2023)

Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
por: Halim, Sandra, et al.
Publicado: (2021)

Rare retinal complications of bone marrow transplantation (BMT): a case report
por: Butt, Farhat, et al.
Publicado: (2018)

THE POWER OF RURAL PARTNERSHIP: MEETING NEEDS AND FOSTERING INNOVATION THROUGH THE WYOMING GWEP
por: McKibbin, Christine, et al.
Publicado: (2022)

Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study
por: Sivaprasad, Sobha, et al.
Publicado: (2021)

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
por: Lois, Noemi, et al.
Publicado: (2019)

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008)

Editorial on the consensus statement on diabetic retinopathy care pathway
por: Sivaprasad, Sobha
Publicado: (2020)

Tackling diabetic retinopathy from the grassroots
por: Sivaprasad, Sobha
Publicado: (2020)

New Advances in Tissue Metabolomics: A Review
por: Saoi, Michelle, et al.
Publicado: (2021)

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial
por: Hykin, Philip, et al.
Publicado: (2019)

Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
por: Pennington, Becky, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uj3gb5s1vo1vb9jb028bl2nlt6